HRAS
Showing 1 - 25 of 59
HRAS Mutations or Peripheral T Cell Lymphoma (PTCL) Trial (Tipifarnib)
Available
- HRAS Mutations or Peripheral T Cell Lymphoma (PTCL)
- (no location specified)
Jun 7, 2022
Urothelial Carcinoma Trial in Seoul (tipifarnib)
Active, not recruiting
- Urothelial Carcinoma
-
Seoul, Korea, Republic ofSamsung Medical Center
Mar 6, 2022
Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)
Not yet recruiting
- Solid Tumors With HRAS Alterations
- +4 more
- (no location specified)
Aug 30, 2023
Non Small Cell Lung Cancer Trial in Spain (Tipifarnib)
Active, not recruiting
- Non Small Cell Lung Cancer
-
Santiago De Compostela, A Coruña, Spain
- +29 more
Sep 21, 2022
Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))
Available
- Pancreatic Cancer
- +20 more
- Ulixertinib (BVD-523)
-
Birmingham, Alabama
- +25 more
Nov 4, 2022
HRAS Gene Mutation, HNSCC Trial in Worldwide (Tipifarnib, HRAS Detection Assay)
Recruiting
- HRAS Gene Mutation
- HNSCC
- Tipifarnib
- HRAS Detection Assay
-
Los Angeles, California
- +131 more
Feb 24, 2021
Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States
Recruiting
- Malignant Solid Neoplasm
- +40 more
- Biospecimen Collection
- +6 more
-
Birmingham, Alabama
- +172 more
Jan 27, 2023
Insulin Dependent Diabetes, Diabetes type2 Trial in Sirnak
Completed
- Insulin Dependent Diabetes
- Diabetes type2
-
Şirnak, Merkez, TurkeyŞirnak Devlet Hastanesi
Jun 22, 2023
Gastric Cancer, Healthy Trial in Hangzhou (No intervention)
Recruiting
- Gastric Cancer
- Healthy
- No intervention
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Aug 7, 2023
Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen
Not yet recruiting
- Malignant Solid Neoplasm
- +4 more
- Binimetinib
- +6 more
- (no location specified)
Nov 8, 2022
NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +3 more
-
Boston, Massachusetts
- +9 more
Dec 22, 2022
ctDNA in Cancer Early Detection and STAS Evaluation in GGOs
Not yet recruiting
- Lung Cancer
- +2 more
- cf DNA and ct DNA
-
Roma, ItalyThoracic Surgery Unit, Sapienza University of Rome
Mar 31, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023
Integrated Molecular Profiling in Advanced Cancers Trial
Active, not recruiting
- Breast Cancer
- +9 more
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Sep 26, 2022
Early Development of Endometrial Carcinoma
Recruiting
- Cancer of Endometrium
-
Ferrara, ItalySection of Obstetrics and Gynecology, Department of Morphology,
Apr 4, 2022
Testing Practices for Common Solid Cancers in Precision Oncology
Active, not recruiting
- Breast Carcinoma
- +5 more
- Survey Administration
-
Chicago, IllinoisCenter for Business Models in Healthcare
Dec 29, 2021
Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,
Not yet recruiting
- Acute Lymphoblastic Leukemia, in Relapse
- +4 more
- Trametinib
- +4 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Dec 13, 2022
MDS Trial in Innsbruck (Next Generation Sequencing, Tumorimmunological examinations - multiplex assays/quantitative polymerase
Recruiting
- Myelodysplastic Syndromes
- Next Generation Sequencing
- +5 more
-
Innsbruck, Tyrol, AustriaMedical University of Innsbruck
Apr 6, 2022
Hospitalism in Children Trial in Richmond (Animal-assisted interaction, Conversational interaction)
Recruiting
- Hospitalism in Children
- Animal-assisted interaction
- Conversational interaction
-
Richmond, VirginiaVirginia Commonwealth University
Jan 10, 2023
Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- Locally Advanced Malignant Solid Neoplasm
- Binimetinib
- +22 more
- (no location specified)
Dec 2, 2022